Stockreport

Deciphera Pharma advancing cancer candidate DCC-3014 [Seeking Alpha]

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations
PDF Results from a Phase 1 clinical trial evaluating Deciphera Pharmaceuticals' (NASDAQ: DCPH ) DCC-3014, a small molecule switch control inhibitor that selectively [Read more]